Dr. Agarwal's Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Agarwal's Health Care Limited has announced the closure of its trading window for all designated persons and their immediate relatives starting March 31, 2026. This is in line with the company's Code of Conduct under SEBI's Insider Trading Regulations, 2015. The closure is triggered by the upcoming finalization and publication of the audited financial results (both standalone and consolidated) for the financial year ending March 31, 2026. The trading window will reopen 48 hours after the financial results are announced by the Board. The exact date of the board meeting for results approval will be communicated later.
This is a routine regulatory compliance filing and does not have a direct impact on shareholders. It restricts insiders from trading the stock ahead of the FY26 audited results announcement, which is expected to come in the coming weeks.